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Background: Modelling competing risks is an essential issue in Nephrology Research. In peritoneal dialysis studies,
sometimes inappropriate methods (i.e. Kaplan-Meier method) have been used to estimate probabilities for an event
of interest in the presence of competing risks. In this situation a competing risk analysis should be preferable. The
objectives of this study are to describe the bias resulting from the application of standard survival analysis to estimate
peritonitis-free patient survival and to provide alternative statistical approaches taking competing risks into account.
Methods: The sample comprises patients included in a university hospital peritoneal dialysis program between
October 1985 and June 2011 (n = 449). Cumulative incidence function and competing risk regression models based on
cause-specific and subdistribution hazards were discussed.
Results: The probability of occurrence of the first peritonitis is wrongly overestimated using Kaplan-Meier method. The
cause-specific hazard model showed that factors associated with shorter time to first peritonitis were age (≥55 years)
and previous treatment (haemodialysis). Taking competing risks into account in the subdistribution hazard model, age
remained significant while gender (female) but not previous treatment was identified as a factor associated with a
higher probability of first peritonitis event.
Conclusions: In the presence of competing risks outcomes, Kaplan-Meier estimates are biased as they overestimated
the probability of the occurrence of an event of interest. Methods which take competing risks into account provide
unbiased estimates of cumulative incidence for each specific outcome experienced by patients. Multivariable
regression models such as those based on cause-specific hazard and on subdistribution hazard should be used in this
competing risk setting.
Keywords: Cause-specific hazard model, Competing risks, Cumulative incidence function, Peritoneal dialysis,
Subdistribution hazard model, Survival analysisBackground
Survival analysis is a statistical method widely used in
medical literature that explores the time period from
a certain point until the occurrence of the event of
interest [1,2].
In peritoneal dialysis (PD) programs, for example,
such approach is used to evaluate patient and technique
survival, peritonitis-free survival and hospitalization-free
survival [3-10].
In various areas of Nephrology research, we are in the
presence of multiple competing events. A competing risk is* Correspondence: laetitiateixeir@gmail.com
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reproduction in any medium, provided the oran event whose occurrence either precludes the occurrence
of another event under examination or fundamentally alters
the probability of occurrence of this other event [11]. For
example, analyzing patient survival in PD program, the
event of interest is death in PD but other events can be
observed: renal transplantation or transfer to haemodialysis.
If one of these two events occurs, the event of interest
cannot be observed.
In PD, few published studies address the competing
risks approach, with emphasis on the research published
by Evans et al. [12]. A very recent publication by
Beuscart et al. [13] also addresses this issue, however
this paper only focuses on univariable methods for
survival analysis. The current paper discusses multivariablel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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analysis taking competing risks into account.
As peritonitis is a major complication in PD program,
it is mandatory to adequately control peritonitis rate and
to evaluate peritonitis-free survival [14].
The objectives of this study are to describe the bias
resulting from the application of standard survival
analysis (Kaplan Meier method) to estimate peritonitis-free
patient survival in a PD program and to provide alternative
statistical approaches taking competing risks into account.
Regression models based on cause-specific hazard and
subdistribution hazard were performed and the estimates
obtained by such models were examined and discussed.
Methods
The sample comprised all patients who started PD between
October 1985 and June 2011 in Peritoneal Dialysis Unit,
Nephrology Department, CHP – Santo António Hospital,
Porto, Portugal. Consecutive incident end-stage renal
disease (ESRD) patients starting PD were identified
from an ongoing registry based prospective study of
quality assessment. Each consecutive patient admitted
in this unit is systematically enrolled for the purpose
of the program control, with regular monthly input of
data related with peritonitis events, hospitalizations,
catheter complications, death, renal transplantation or
transfer of modality with respective causes. Patients
follow 1-2 monthly regular visits and clinical pathways
according to the International Guidelines are used [15].
Within the quality control procedures, the profile of clinical
complications and survival curves are audited. Patient
outcome was defined as the earliest event among: first
episode of peritonitis, death, transfer to haemodialysis
and renal transplantation. Peritonitis was defined
based on International Guidelines [15]. Transfer to
haemodialysis was defined as definite drop-out from
peritoneal dialysis. Registry data collection and analysis
was submitted to ethical appreciation and approved by the
National Commission of Data Protection, which is the
national supervisory authority for personal data control.
Statistical methods
Competing risks and cumulative incidence function
Standard survival analysis methods have been commonly
used to analyze competing risks data. But, sometimes,
inappropriate methods such as the complement of
Kaplan-Meier estimate (1-KM) have been applied to
estimate probabilities of the occurrence of an event of
interest in a competing risks setting [11]. The 1-KM
cannot be interpreted as the actual probability of the
occurrence of an event by time t [16]. In this classical
analysis there is an event of interest and all other
events are censored. The assumption of this method
is of non-informative censoring. This assumptionconsiders that censored patients have the same probability
of experiencing the event as patients who remain under
follow-up. However, in the presence of multiple competing
outcomes, this assumption is not verified [17]. These
estimates have been interpreted as the probability of
an event of interest in an ideal world where the other
types of events do not exist [16,18]. Although, in the
presence of competing risks, each event has a hazard.
Therefore, the number of failures from the competing
risks will reduce the actual number of failures from
the event of interest and consequently, influence the
estimate of the probability of failure from this event
[11]. In these situations, the cumulative incidence
function is the appropriate tool to analyse such data.
Cumulative incidence function for a specific event,
also known as the subdistribution function [16], is
defined as the probability of failing from a given
cause in the presence of competing events, given
that a subject has survived or has already failed due to
different causes [16,19,20].
In the present study, the estimate of the cumulative
incidence for a specific event was calculated based
simultaneously on the estimate of the overall survival
function when all types of events are considered and
on the hazard estimate of the specific event [16,21].
Then, the cumulative incidence function for a specific
event depends not only on the number of individuals
who have experienced this type of event, but also on
the number of individuals who have not experienced
any other event [16].
This function is often of interest in medical research
and its graphical display over time is intuitive and
appealing [20,22].
To analyze differences in the cumulative incidence
between various patient groups, Gray’s test was used [19].
Comparing the cumulative incidence functions gives an
idea of the probability of occurrence of the event of interest
and therefore can be translated into an actual number of
patients with the event of interest [16].
Multivariable regression models
In the multivariable analysis, two types of models were
performed considering two types of hazard: cause-specific
hazard and hazard of the subdistribution. The cause-
specific hazard at time t is a fundamental concept in
competing risks, defined by the instantaneous risk of
failure per time unit from the event of interest given
survival till just before t [23]. This hazard measures
the instantaneous failure rate due to one risk [1]. The
hazard of the subdistribution is interpreted as the
probability of observing an event of interest in the
next time interval while knowing that either the event
of interest did not happen until then or that a competing
risks event was observed [16].
Table 1 Characteristics of the patients
n %
Gender
Male 175 39.0
Female 274 61.0
Age* 48.2 (15.8)
Outcome
First peritonitis 238 53.0
Death 46 10.2
Transfer to haemodialysis 58 12.9
Renal transplantation 65 14.5
Censored 42 9.4
Diabetes
Yes 100 22.5
No 345 77.5
First treatment
Peritoneal dialysis 244 54.4
Haemodialysis 151 33.6
Renal transplantation 54 12.0
Reason for peritoneal dialysis
Option 259 57.9
Access failure 188 42.1
*Mean (SD).
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for competing risks data involves modelling the cause-
specific hazard functions of the different failure types [24].
Proportional cause-specific hazards regression models
can be estimated using the standard Cox regression
and censoring patients with competing events at the
time point of their occurrence [25]. The utilization of
Cox regression models for cause-specific hazards has
the advantage that they are easy to fit and they provide
parameter estimates which possess simple rate ratio
interpretations. Such models, however, do not provide
simple relationships between covariates and the easier
interpretable cumulative incidences [23].
Models on subdistribution hazards The model pro-
posed by Fine and Gray [24] is based on the hazard of
the subdistribution and provides a simple relationship
between covariates and cumulative incidence [23]. As
in any other regression analysis, modelling cumulative
incidence functions for competing risks can be used
to identify potential prognostic factors for a particular
failure in the presence of competing risks, or to
assess a prognostic factor of interest after adjusting
for other potential risk factors in the model [20].
However, this analysis cannot be fully interpreted
without examining the effect of the covariates on the
competing risks [16,26].
In the present study, to analyze peritonitis-free
survival, the event of interest was the first episode
of peritonitis and the competing risk events were
death, transfer to haemodialysis and renal transplantation.
Patients with partial recovery of renal function before the
first episode of peritonitis were excluded (given the small
number involved (n = 6)). Patients without any of these
outcomes were censored at the date of their last recorded
visit or at the end of the study period (June 2011).
Other variables, such as gender, age groups (<55 years;
≥55 years) [27], diabetes (yes; no), and first renal replace-
ment therapy (PD; haemodialysis; renal transplantation),
were evaluated.
Survival analysis methods taking competing risks into
account were performed for analyzing peritonitis-free
survival. First, estimates of cumulative incidence
function were calculated and compared with 1-KM
estimates. Then, subgroup analyses, using Gray’s test,
were conducted considering the patient characteristics.
Finally, regression models taking competing risks into
account (Cox cause-specific hazard model and Fine and
Gray model based on subdistribution hazard model) were
carried out to analyze the effect of covariates in the
peritonitis-free survival. To decide which variables should
be included in the multivariable models, an exploratory
analysis was performed by fitting univariable models and
considering as candidates for the multivariable model allvariables significant at the 0.10 significance level in these
univariable models. For the final multivariable models, the
significance level was set at 0.05 and they were built
including all variables with p-values <0.05.
All analyses were performed with R software using the
packages coxph and cmprsk.
Results
Sample
The final sample comprises 449 patients, 61.0% women
(n = 274) and the mean age was 48.2 years (sd = 15.8 years).
Median follow-up was 10 months (range 0-118 months).
First peritonitis episode was the commonest outcome
(n = 238, 53.0%). Renal transplantation was the main
reason for PD discontinuation (n = 65, 14.5%), followed by
transfer to haemodialysis (n = 58, 12.9%) and death (n = 46,
10.2%). At the end of the study period, 9.4% of the patients
were still on PD having not experienced a peritonitis
episode (n = 38) or were lost to follow-up (n = 4). More
than half of the patients were PD first (i.e. the first renal
replacement therapy was PD), 22.5% had diabetes and
57.9% had started PD by option (Table 1).
Cumulative incidence estimates
Figure 1 summarizes the cumulative incidence estimates
for all possible outcomes taking competing risks into
Figure 1 Cumulative incidence curves for all possible
outcomes, taking competing risks into account.
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because the proportion of patients free of an event, but still
in follow-up, becomes small). For example, the probabilities
of experiencing peritonitis by 1, 3 and 5 years after starting
PD were 0.34, 0.52 and 0.55, respectively.Kaplan-Meier method vs cumulative incidence function
Figure 2 presents the curves for the cumulative incidence
function of the occurrence of the event of interest
obtained using two different methods: method taking
competing risks into account and the complement of
Kaplan-Meier method.Figure 2 The complement of the Kaplan-Meier estimate and
the cumulative incidence estimate for first peritonitis.The appropriate competing risks approach results in a
lower estimate of cumulative incidence. The magnitude
of the differences between incidences of first peritonitis as
calculated using the two methods increases with period of
follow-up. In other words, the actual probability of
occurrence of the first peritonitis is wrongly overestimated
using Kaplan-Meier method and the longer the duration of
follow-up the larger the difference between the estimated
by these two methods.
Subgroup analyses, using Gray’s test, were performed
calculating cumulative incidence for all possible events
according to the variables gender, age, diabetes, first
treatment and reason for PD.
Considering first peritonitis as the event of interest
only age groups was statistically significant (p = 0.008).
Figure 3 shows the cumulative incidence curves for the
first peritonitis in the two age groups and it can be seen
that the group of older patients (≥55 years) presents
always a higher risk of peritonitis.
When considering the competing risks events, death
and renal transplantation, age was a significant factor
conditioning the probability of these events (p = 0.005
and p < 0.001, respectively). Older patients showed a
higher hazard risk of death and a lower hazard risk of
renal transplantation compared with younger patients.
Patients with diabetes presented a higher hazard risk of
death (p = 0.037).
Regression models
Tables 2 and 3 give a summary of the unadjusted and
adjusted effects of covariates for first peritonitis based
on the two types of modelling: cause-specific hazard
models and subdistribution hazard models.Figure 3 Cumulative incidence curves for first peritonitis
outcomes, according to age groups.
Table 2 Cox proportional hazard regression (cause-specific
hazard model) for the event of interest (first peritonitis)
Unadjusted model Adjusted model
HR 95% CI p HR 95% CI p
Gender
Female 1.24 0.95-1.62 0.12
Male 1 - -
Age
≥55 years 1.37 1.06-1.78 0.017 1.35 1.03-1.76 0.030
<55 years 1 - - 1 - -
Diabetes
Yes 0.92 0.66-1.28 0.63
No 1 - -
First
treatment
HD 1.45 1.10-1.91 0.009 1.44 1.09-1.90 0.009
TR 0.95 0.62-1.46 0.82 1.06 0.68-1.64 0.791
PD 1 - - 1 - -
Reason
for PD
Access failure 1.21 0.93-1.57 0.15
Option 1 - -
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the event of interest (first peritonitis), it was found that
the variables age and first treatment were significant in
the cause specific-hazard model (Table 2) and only the
variable age was significant in the subdistribution hazard
model (Table 3).
The results show that the effects of age for the
cause-specific and subdistribution hazard models are
quite close for the event of interest, first peritonitis.
Considering the cause-specific multivariable model,
risk of peritonitis increased with age (HR = 1.35, 95%
CI = 1.03-1.76). Risk of peritonitis was also higher for
patient with haemodialysis as first treatment compared
with PD first (HR = 1.44, 95% CI = 1.09-1.90) (Table 2).
The effect of gender when adjusted for age groups and
first treatment remains non-significant (HR = 1.28, 95%
CI = 0.97-1.69).
Unlike the cause-specific hazard model, the sub-
distribution multivariable model found both gender
and age group statistically significant but not first
treatment. Females were at 32% higher hazard risks
of first peritonitis compared to male (sHR = 1.32, 95%
CI = 1.02-1.72) and age equal or greater than 55 had
1.47 times higher risk of peritonitis (sHR = 1.47, 95%
CI = 1.14-1.89) compared to those younger than
55 years (Table 3).
This analysis cannot be fully interpreted without
examining the effect of these covariates on the competing
risks because the results are influenced by the way the
competing risks were distributed. Given that women have
a slightly lower probability of experiencing the competing
risks (renal transplantation and transfer to haemodialysis),
the event of interest could be observed and therefore the
effect of gender becomes larger. Analyzing the competing
events, patients aged equal or greater than 55 years hadlower risk of renal transplantation compared to those aged
younger than 55 in the subdistribution hazard model
(sHR = 0.19, 95% CI = 0.09-0.41). All the remaining
variables were found not to be statistically significant.
Discussion and conclusions
This study addresses a clinically relevant methodological
issue, focused on peritonitis events under PD. While
peritonitis has been chosen as an example of a main event,
our study discusses the application of competing risk
analysis in dialysis populations by exploring multivariable
models that allow clinicians to answer relevant questions
related with any other serious event: who is at a higher risk
of peritonitis, death, transfer to HD? But if a certain patient
is younger and will have faster access to transplantation, for
example, will that risk be the same? Dialysis policies and
patients certainly need this kind of approaches to more
accurately predict the risks.
When analysing peritonitis-free patient survival, a
relevant overestimation was presented when Kaplan-Meier
method was used, revealing the importance of using the
competing risks approach in survival analysis in PD. In the
presence of competing risks outcomes, the Kaplan-Meier
core assumption of non-informative censoring does not
hold: the presence of competing risk events results in
informative censoring [1,28]. Previous work has shown
that 1-KM and cumulative incidence function, each of
which is commonly used to estimate the probability of
failure, can result in different estimates when competing
risks are present. The bias resultant of this approach
is especially great when the hazard of the competing
risks is large [26].
In our study and using the more appropriate method-
ology we were able to document that the probabilities of
experiencing a first peritonitis by 1, 3 and 5 years after
starting PD were 0.34, 0.52 and 0.55, respectively.
Additionally age (≥55 years) and gender (female) were
identified as factors associated with a higher probability
of first peritonitis occurrence, but not diabetes or
previous renal replacement modality in the subdistribution
multivariable regression model. This methodology indicates
that in our program the use of PD was feasible in diabetics
and non-naïve PD patients, coming from haemodialysis or
after renal graft failure, without significantly higher risk of
experiencing a first peritonitis episode. Previous studies
have identified association between peritonitis and other
risk factors [12], but this study was mainly designed
to perform a critical appraisal of the methodology
used in the competing risk setting and not to fully
examine all independent risk factors for peritonitis.
As we have mentioned, two approaches can be used when
competing risks are present: modelling the cause-specific
hazard and modelling the hazard of the subdistribution
(taking into account the competing risks). But the
Table 3 Fine and Gray model (hazard of the subdistribution model) for all possible events
Unadjusted model Adjusted model
sHR 95% CI p sHR 95% CI p
First peritonitis
Gender
Female 1.26 0.97-1.63 0.085 1.32 1.02-1.72 0.037
Male 1 - - 1 - -
Age
≥55 years 1.41 1.10-1.82 0.007 1.47 1.14-1.89 0.003
<55 years 1 - - 1 - -
Diabetes
Yes 0.79 0.57-1.09 0.15
No 1 - -
First treatment
HD 1.28 0.98-1.68 0.069
TR 0.99 0.65-1.53 0.98
PD 1 - -
Reason for PD
Access failure 1.13 0.87-1.45 0.36
Option 1 - -
Death
Gender
Female 1.08 0.58-1.99 0.81 1.19 0.64-2.23 0.58
Male 1 - - 1 - -
Age
≥55 years 2.23 1.23-4.02 0.008 2.27 1.24-4.15 0.007
<55 years 1 - - 1 - -
Diabetes
Yes 1.85 1.00-3.42 0.05
No 1 - -
First treatment
HD 1.47 0.79-2.72 0.22
TR 0.84 0.29-2.45 0.75
PD 1 - -
Reason for PD
Access failure 1.81 1.00-3.29 0.05
Option 1 - -
Renal transplantation
Gender
Female 0.92 0.56-1.50 0.73 0.82 0.50-1.33 0.42
Male 1 - - 1 - -
Age
≥55 years 0.19 0.09-0.42 <0.001 0.19 0.09-0.41 <0.001
<55 years 1 - - 1 - -
Diabetes
Yes 0.79 0.42-1.49 0.46
No 1 - -
First treatment
HD 0.58 0.32-1.06 0.076
TR 1.08 0.56-2.11 0.82
PD 1 - -
Reason for PD
Access failure 0.65 0.39-1.09 0.10
Option 1 - -
Transfer for haemodiaysis
Gender
Female 0.81 0.48-1.36 0.43 0.79 0.47-1.32 0.36
Male 1 - - 1 - -
Age
≥55 years 0.73 0.41-1.28 0.27 0.71 0.41-1.24 0.23
<55 years 1 - - 1 - -
Diabetes
Yes 1.64 0.94-2.85 0.08
No 1 - -
First treatment
HD 1.17 0.67-2.04 0.59
TR 1.23 0.57-2.65 0.90
PD 1 - -
Reason for PD
Access failure 1.28 0.76-2.14 0.35
Option 1 - -
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the subdistribution hazards models may be different
[26], as found in this study. The objective of the first
approach is to test whether the peritonitis incidence
rate is different between groups. So, we may point to an
etiologic factor or relevant clinical factor with biological
relevance. In the second approach the interest is to estimate
how many more (or less) peritonitis cases are seen in each
group. The presence of competing risks influences the
number of events observed, since a person who has
experienced a competing risk (death, transfer to
haemodialysis or renal transplantation) will no longer
have the chance of having peritonitis. The results
obtained in the subdistribution hazard model are
influenced by the way the competing risks were distributed.
If patients with a characteristic were more likely to have a
competing risk, the event of interest could not be
observed and therefore the effect of this covariate
would be diminished [16]. This may explain why the
variable first treatment was found to be statistically
significant in the cause-specific hazard model but not
in the subdistribution model.
Both models were performed because the choice
between the two approaches is based on the research
question and the two analyses may complement each
other. For etiologic questions, a cause-specific hazards
model is generally more appropriate, since it quantifies the
event rate among the ones at risk of developing the event
of interest. However since the focus is often on the direct
assessment of actual risks and therefore the purpose of
prediction and medical decision making, subdistribution
regression models for the cumulative incidence function
are preferred [23,25,29].
In fact, cause-specific hazards (CSH) and cumulative
incidence functions (CIF) provides different aspects of the
event histories in competing risks problems and inference
on these measures may yield different conclusions. Given
the complementary nature of these approaches, a universal
recommendation for all problems would not be appropriate
and inference should be based on a priori choice of the
primary question to be addressed.
In competing risks problems, CSH is a fundamental
measure and the most commonly used. It is appropriate
for investigating the effect of a covariate on the rate of
occurrence of an event in the presence of all types of
events. CIF is useful for evaluating the effect of a covariate
on the probability of the occurrence of an event of interest
over a meaningful period of time. This is the best measure
for absolute risk calculations and risk prediction. Results
of CIF analysis should always be reported for all events
(interest and competing events) [19,30,31].
In the area of PD, there are few published works that
address the competing risks approach. In their study,
Evans et al. [12] analyzed the peritonitis-free survivaland the results obtained are similar to our study, revealing
the overestimation of cumulative incidence estimation
obtained by Kaplan-Meier method. Quinn et al. [32]
present a reflection about the importance and relevance of
survival analysis taking competing risks into account, when
competing risks events are present, illustrating this situ-
ation with an example on PD. Beuscart et al. [13] also
discussed competing risk approach and applied univariable
survival analysis. In our study we discuss further this topic
and illustrated how the methodology should be used when
investigating other serious events in dialysis populations
using a multivariable approach.
The relevance of the present critical investigation is
that it can be applied to any other PD serious event
such as death or technique failure. Furthermore, the
multivariable approach presented in the current paper
is relevant to other areas of nephrology namely in the
evaluation of haemodialysis programs (where renal
transplantation and transfer to PD are competing
risks) or in renal transplantation when analysing graft
failure (where death with functioning graft could be
considered a competing event).
Apart from these clinical issues we highlight that
methods which take competing risks into account
provide unbiased estimates of cumulative incidence
for each specific outcome experienced by patients. With
competing risks packages available in some standard stat-
istical software (e.g. SPSS, SAS, STATA or R), it is hoped
that they may become more widely used in renal research.
In conclusion, a competing risk approach to estimating
cumulative incidence in studies with multiple outcomes,
specifically in PD studies, will result in more rigorous
estimates and is recommended.
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